|
|
Volumn 9, Issue 5, 2000, Pages 411-421
|
|
The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis
a,c
|
|
Author keywords
Cost effectiveness; Guidelines; Implentation; Screening; Tuberculosis
|
|
Indexed keywords
BCG VACCINE;
ETHAMBUTOL;
ISONIAZID;
PYRAZINAMIDE;
PYRIDOXINE;
RIFAMPICIN;
ARTICLE;
AUSTRALIA;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DISEASE CONTROL;
DRUG EFFICACY;
EVIDENCE BASED MEDICINE;
EXPOSURE;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH PROGRAM;
HUMAN;
HYPOTHESIS;
INFECTION PREVENTION;
INFECTION RISK;
MASS SCREENING;
OUTCOMES RESEARCH;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SOCIAL BEHAVIOR;
STATISTICAL ANALYSIS;
THORAX RADIOGRAPHY;
TREATMENT OUTCOME;
TUBERCULOSIS;
ANTITUBERCULAR AGENTS;
CONTACT TRACING;
COST OF ILLNESS;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
EVIDENCE-BASED MEDICINE;
HUMAN;
ISONIAZID;
MASS SCREENING;
MODELS, ECONOMETRIC;
NEW SOUTH WALES;
PRACTICE GUIDELINES;
SUPPORT, NON-U.S. GOV'T;
TUBERCULOSIS;
|
|
EID: 0033864823
PISSN: 10579230
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-1050(200007)9:5<411::AID-HEC524>3.0.CO;2-9 Document Type: Article |
|
Times cited : (23)
|
|
References (31)
|
